Article
ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling
23 Sept 2021
Abstract excerpt
ISG15 is an ubiquitin-like modifier that is associated with reduced survival rates in breast cancer patients. The mechanism by which ISG15 achieves this however remains elusive. We demonstrate that modification of Rab GDP-Dissociation Inhibitor Beta (GDI2) by ISG15 (ISGylation) alters endocytic recycling of the EGF receptor (EGFR) in non-interferon stimulated cells using CRISPR-knock out models for ISGylation. By...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
